|
|
|
Corporate Profile: AVI
BioPharma
| Summary: |
AVI BioPharma
is involved in developing drugs to treat life-threatening
diseases using third-generation antisense technology. |
| Address: |
One SW Columbia
Street
Suite 1105
Portland, OR 97258 |
4575 SW Research Way
Suite 200
Corvallis, OR 97333 |
| Phone
#'s: |
Main |
(503) 227-0554 |
(541) 753-3635 |
| Human Resources |
not known |
not known |
| Investor Relations |
(503) 227-0554 |
not known |
| Fax
#'s: |
Main |
(503) 227-0751 |
| Human Resources |
not known |
| Investor Relations |
not known |
| email: |
Main |
avi@avibio.com |
| Human Resources |
not known |
| Investor Relations |
not known |
| Financial
information: |
| AVII |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
